Key opinion leaders explore the clinical and economic burden of dementia-related psychosis and the unmet medical need.
Kevin U. Stephens, Sr, JD, MD, provides a payer perspective on the unmet needs in the management of dementia-related psychosis. He then provides an overview of quality measures monitored for patients with dementia, including cognitive assessment, functional status, neuropsychiatric symptoms, and depressive symptoms. Dr Stephens next discusses the systems in place to ensure quality care for patients with dementia and the importance of reimbursement for comprehensive clinical visits in the evaluation and diagnosis of dementia-related psychosis.
The speakers are paid consultants on behalf of Acadia Pharmaceuticals Inc. This is a disease-awareness, non-CME program sponsored by Acadia Pharmaceuticals Inc.
Click here to watch the previous video in this series.
Click here to watch this series from the beginning.